ArticleCancer medicine2023

Phase I study of plitidepsin in combination with bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma.

María Victoria Mateos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.